ACH
CDNA icon

ArrowMark Colorado Holdings’s CareDx CDNA Stock Holding History

ArrowMark Colorado Holdings’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.65M Sell
338,549
-148,119
-30% -$3.22M 0.4% 95
2026
Q1 		$8.45M Sell
486,668
-271,732
-36% -$5.14M 0.22% 136
2025
Q4 		$14.3M Sell
758,400
-208,516
-22% -$3.49M 0.31% 91
2025
Q3 		$14.1M Buy
966,916
+247,709
+34% +$3.53M 0.26% 100
2025
Q2 		$14.1M Buy
719,207
+396,714
+123% +$7.05M 0.25% 105
2025
Q1 		$5.72M Buy
+322,493
New +$6.95M 0.09% 167
2023
Q2 		– Sell
-238,691
Closed -$2.18M – 309
2023
Q1 		$2.18M Sell
238,691
-3,764,527
-94% -$48.2M 0.02% 228
2022
Q4 		$45.7M Buy
4,003,218
+914,713
+30% +$13.6M 0.55% 56
2022
Q3 		$52.6M Buy
3,088,505
+201,396
+7% +$4.32M 0.64% 52
2022
Q2 		$62M Buy
2,887,109
+530,911
+23% +$14.7M 0.71% 45
2022
Q1 		$87.2M Buy
2,356,198
+617,264
+35% +$24.1M 0.76% 40
2021
Q4 		$79.1M Buy
1,738,934
+891,581
+105% +$46.5M 0.63% 45
2021
Q3 		$53.7M Buy
847,353
+209,791
+33% +$16M 0.42% 69
2021
Q2 		$58.4M Buy
637,562
+327,699
+106% +$26M 0.44% 70
2021
Q1 		$21.1M Sell
309,863
-172,502
-36% -$13.4M 0.16% 126
2020
Q4 		$34.9M Sell
482,365
-267,147
-36% -$15.5M 0.27% 97
2020
Q3 		$28.4M Sell
749,512
-81,438
-10% -$2.75M 0.27% 87
2020
Q2 		$29.4M Sell
830,950
-194,878
-19% -$5.55M 0.3% 80
2020
Q1 		$22.4M Buy
1,025,828
+322,513
+46% +$7.23M 0.29% 90
2019
Q4 		$15.2M Buy
703,315
+106,796
+18% +$2.45M 0.13% 133
2019
Q3 		$13.5M Buy
596,519
+41,036
+7% +$1.14M 0.13% 131
2019
Q2 		$20M Sell
555,483
-170,298
-23% -$5.45M 0.19% 109
2019
Q1 		$22.9M Sell
725,781
-116,903
-14% -$3.41M 0.22% 105
2018
Q4 		$21.2M Sell
842,684
-53,790
-6% -$1.38M 0.22% 110
2018
Q3 		$25.9M Sell
896,474
-442,094
-33% -$8.27M 0.22% 106
2018
Q2 		$16.4M Buy
+1,338,568
New +$15.3M 0.15% 134

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ArrowMark Colorado Holdings's CDNA Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its CareDx (CDNA) stake by 30% in Q2 2026, selling an estimated $3.22M and leaving 338,549 shares worth $9.65M. The position accounts for 0.4% of the portfolio, ranked #95.

ArrowMark Colorado Holdings first reported a position in CDNA in Q2 2018 and has held it in 26 quarters since. The position peaked at $87.2M in Q1 2022. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • ArrowMark Colorado Holdings held 338,549 shares of CareDx worth $9.65M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 148,119 CareDx shares in Q2 2026, an estimated $3.22M.
  • CareDx made up 0.4% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #95 holding.
  • ArrowMark Colorado Holdings first reported a position in CareDx in Q2 2018 and has held it in 26 quarters since.
  • ArrowMark Colorado Holdings's CareDx position peaked at $87.2M in Q1 2022.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.